PCM TRIALS - Quality Mobile Research

❄️Wishing you a happy holiday season from PCM Trials!❄️ As the year comes to a close, we’re reflecting on the meaningful moments that shaped 2024. This year, we’ve experienced tremendous growth, allowing us to reach more patients and communities than ever before. From empowering participants with community-based research to partnering with innovative sponsors and CROs, we’ve worked together to bring research to life – whenever and wherever life happens. We’re deeply thankful for the dedication of our clinicians, the trust of our partners, and the invaluable contributions of every participant who joined us on this journey. Together, we’re reimagining the clinical trial experience and delivering results that truly matter. Here’s to a new year filled with innovation, collaboration, and continued progress! #HappyHolidays #ClinicalResearch #CommunityResearch

Social determinants of health (SDOH) like housing, transportation, and social support play a powerful role in clinical trial participation. Yet, they’re often overlooked. Discover why addressing SDOH isn’t just important—it’s essential for achieving diversity, improving patient retention, and ensuring real-world relevance in study results. Ready to unlock the potential of inclusive research? Dive into this insightful article: https://hubs.ly/Q02_WvfD0 #ClinicalTrials #HealthEquity #SDOH #DiversityInResearch #PatientRecruitment #EmVenioImpact

The data is clear: underrepresented populations still face major barriers to clinical trial participation. From 2017-2024, over 70% of US-based trial participants identified as white, leaving underrepresented groups largely excluded. At the same time, mentions of ‘diversity in clinical trials’ in sponsor filings have surged by 300% , signaling an urgent commitment to change. Community-based research models reduce logistical and geographical barriers, broadening trial accessibility for traditionally underrepresented populations. By meeting patients in their homes and communities, we help sponsors meet FDA diversity benchmarks and ensure equitable, representative research. Learn more about how community-based research models extend the reach of clinical trials to facilitate greater participation for underrepresented groups in our latest article: https://lnkd.in/gtsBzZ3B #AccessForAll #EquityInResearch #Diversity #ClinicalTrialDiversity  

In our most recent webinar, Stephanie Hitchcock and Kristofer Booth, MBA explored recent FDA guidance on diversity in clinical trials, emphasizing the critical role of diversity action plans in improving enrollment and retention of underrepresented populations. The conversation focused on how to make highly inclusive trials a reality through actionable, patient-centric strategies, including the use of mobile visits and community-based research sites. These approaches help remove barriers to participation to expand the reach of clinical trials and ensure that research reflects the diversity needed to drive better health outcomes for all. Interested in learning more? Watch the full webinar below, or read some of the key takeaways here: https://lnkd.in/g_t8_vbC #AccessForAll #InclusiveResearch #CommunityResearch #DiversityInResearch  

November is National Alzheimer's Awareness Month! With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s - and projections reaching nearly 13 million by 2050 - addressing the unique needs of this population is critical. Alzheimer’s patients often face significant barriers to trial participation, from mobility challenges to the need for caregiver support, making accessible and inclusive research solutions essential. At PCM Trials, we are proud of our deep history of advancing Alzheimer’s research through our community-based research model. By delivering research services directly to participant’s homes and enabling caregiver participation, we’re removing barriers and improving access for those impacted by Alzheimer's. Learn how mobile visits and community research support greater trial accessibility for aging populations here: https://lnkd.in/dBZtWgNh Join us in raising awareness by sharing how we can better support Alzheimer’s patients and caregivers! #AlzheimersAwareness #CommunityResearch #AccessForAll #AlzheimersAwarenessMonth

After months of hard work, we’re thrilled to debut our public television feature created in partnership with Viewpoint Project with Dennis Quaid. Our segment begins airing nationally this week, and you can watch the episode below! 📺 In this educational docuseries, we’re showcasing how our community-based mobile visits and clinical research sites are revolutionizing clinical trials by making them more accessible, increasing participant recruitment and retention rates, and promoting diversity. As the largest independent community site network and the most experienced provider of local clinical trial access globally, PCM Trials and EmVenio Research (a PCM Trials company) are delivering research services to underrepresented participants wherever they are - in their homes, workplaces, and communities. Watch the episode here: https://lnkd.in/gk3vsrMk #AccessForAll #CommunityResearch #HealthcareInnovation

In an interview at #DIA2024 earlier this year, Jonathan Ernst, Vice President of In-Home Solutions at PCM Trials, shared how we at PCM Trials and EmVenio Research are working to bridge critical gaps in clinical trial access to create a seamless participant journey. From early community outreach to the final visit, we’re dedicated to supporting participants and sponsors throughout the entire study process. By combining mobile visits and community-based elements, we are extending the reach of clinical research with a personalized approach. Learn more about our commitment to participant optionality and creating a truly accommodating trial experience here: https://lnkd.in/gsUjfCyP #AccessForAll #PatientCentricity #CommunityResearch #ClinicalResearch 

Just a few days left! Don’t miss our webinar: Building Your Toolkit: How to Operationalize FDA Guidance on Diversity November 14, 2024, at 10:00 am ET Hear from Stephanie Hitchcock and Kristofer Booth, MBA as they dive into the latest FDA guidance on diversity. Learn practical strategies for integrating diversity into trial designs to help meet inclusivity goals and align with regulatory requirements in your studies. Register here: https://lnkd.in/gthAb-X9 #ClinicalResearch #DiversityInResearch #AccessForAll #Webinar #CommunityResearch #DiversityInTrials

The EmVenio and PCM TRIALS - Quality Mobile Research team is excited to attend the Decentralized Trials & Research Alliance (DTRA) event in Boston this week, from November 13-16. We are looking forward to connecting with industry experts on the theme of "Access for All" and showcasing how PCM Trials and EmVenio are successfully reaching participants via mobile visits and community research sites, ensuring access for everyone. See one of our latest articles exploring clinical trial access: https://lnkd.in/dKRGw3PZ #DTRA2024 #ClinicalReserach #CommunityResearch #access

We are thrilled to be in Boston celebrating the 15 year anniversary of #CNSSummit! 🎉   Visit our team at booth #309 to learn how our community-based research model is expanding the reach of clinical trials and meet Dr. Sutton, a leading authority in Alzheimer’s, Parkinson’s, pain management, infectious diseases, and immunology with over 23 years of research expertise.   #AccessForAll #CommunityResearch #HealthcareInnovation